Date Filed | Type | Description |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/16/2021 |
4
| Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Sold 433 shares
@ $4.4, valued at
$1.9k
|
|
10/15/2021 |
4
| Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Sold 430 shares
@ $8.65, valued at
$3.7k
|
|
09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2021 |
4
| Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Sold 445 shares
@ $10.68, valued at
$4.8k
|
|
07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
07/15/2021 |
4
| Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Sold 431 shares
@ $11.01, valued at
$4.7k
|
|
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/16/2021 |
4
| Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Sold 499 shares
@ $20.45, valued at
$10.2k
|
|
02/19/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/21/2019 |
4
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Sold 940 shares
@ $5.35, valued at
$5k
|
|
04/10/2019 |
4
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 30,000 shares
@ $0 Granted 60,000 options to buy
@ $6.81, valued at
$408.6k
|
|
03/21/2019 |
4
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Sold 1,792 shares
@ $7.99, valued at
$14.3k
|
|
12/21/2018 |
4
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Sold 425 shares
@ $7.52, valued at
$3.2k
|
|
06/22/2018 |
4
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Sold 1,002 shares
@ $25.48, valued at
$25.5k
|
|
03/22/2018 |
4
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Sold 982 shares
@ $25.89, valued at
$25.4k
|
|
03/09/2018 |
4
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 6,250 shares
@ $0 Granted 37,500 options to buy
@ $25.66, valued at
$962.3k
|
|
12/21/2017 |
4
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Sold 440 shares
@ $32.3, valued at
$14.2k
|
|
06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/17/2017 |
4/A
| Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc |
01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/08/2016 |
4
| Rhodes Jennifer J (General Counsel) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 4,687 shares
@ $0 Granted 28,125 options to buy
@ $14.26, valued at
$401.1k
|
|
05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/14/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/29/2013 |
3
| Rhodes Jennifer J (GC & Chief Compliance Officer) has filed a Form 3 on MEDIVATION, INC. |
03/29/2013 |
3
| Rhodes Jennifer J (GC & Chief Compliance Officer) has filed a Form 3 on MEDIVATION, INC. |